Shumaila Tunio, Ph.D., M.SC., MBA

Associate Professor of Microbiology

  • Office: Coal Building, 718
  • Telephone: (606) 218-5551
  • E-mail: ShumailaHanif@upike.edu

Medical Immunology
Medical Microbiology
Infectious Diseases
General Microbiology
Biochemistry
Integrated Case Studies
Critical Evaluation of Medical Literatures
Laboratory Research Methods
Techniques in Molecular Biology

MBA in Professional track, Coleman College of Business, University of Pikeville, Pikeville, KY. USA
BSc, Microbiology, Faculty of Science, Kuwait University, Kuwait
MSc, Medical Microbiology, Faculty of Medicine, Kuwait University, Kuwait
PhD, Medical Microbiology, Faculty of Medicine, Kuwait University, Kuwait

1. Hanif SNM, Al-Attiyah R, Mustafa AS. Antibody Reactivity to Mycobacterium tuberculosis Specific RD1 and RD9 Proteins and Peptides in Rabbits, Mice and Humans. International Journal of Mycobacteriology. 2023; 12(4):448-458.

(https://journals.lww.com/ijmy/fulltext/2023/12040/antibody_reactivity_to_mycobacterium.14.aspx)

2. Garcia-Contreras L, Hanif SNM, Ibrahim M, Durham P, Hickey AJ. The Pharmacokinetics of CPZEN-45, a Novel Anti-Tuberculosis Drug, in Guinea Pigs. Pharmaceutics. 2023; 15(12):2758. (https://doi.org/10.3390/pharmaceutics15122758).

3. Hargrave A, Mustafa AS, Hanif A, Tunio JH, Hanif SNM. Recent Advances in Cancer Immunotherapy with a Focus on FDA-Approved Vaccines and Neoantigen-Based Vaccines. Vaccines (Basel). 2023; 11, 1633. (https://doi.org/10.3390/vaccines11111633)

4. Khan S, Zargaham MK, Lail A, Naqvi SF, Hanif SNM. Endogenous and Exogenous Natural Sources of Inhibition of Arachidonic acid-induced Platelet aggregation. Phytopharmalogical Communications. 2022; 2.

(https://rootspress.org/journals/index.php/PPC/article/view/47/475).

5. Sydow E, Mustafa AS, Hanif A, Tunio J, Hanif SNM. Recent Updates on mRNA Vaccines. Vaccines (Basel). 2022, 10, 1209. (https://doi.org/10.3390/vaccines10081209).

Postdoctoral Fellowship, Department of Phamaceutical Sciences, University of Oklahoma Health Science Center

Developing new diagnostic methods, new drugs and new vaccines for Tuberculosis

Educational and Clinical Research